Trademark: 88622870
Word
DE-CART
Status
Dead
Status Code
606
Status Date
Monday, December 19, 2022
Serial Number
88622870
Mark Type
4000
Filing Date
Thursday, September 19, 2019
Published for Opposition
Tuesday, March 16, 2021
Abandoned Date
Monday, December 19, 2022

Trademark Owner History
Nurix Therapeutics, Inc. - Owner At Publication

Classifications
5 Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders
42 Research and development in the pharmaceutical and biotechnology fields

Trademark Events
Dec 19, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 19, 2022
Abandonment - No Use Statement Filed
Apr 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 27, 2022
Sou Extension 2 Granted
Apr 27, 2022
Sou Extension 2 Filed
Apr 27, 2022
Teas Extension Received
Oct 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 28, 2021
Sou Extension 1 Granted
Oct 28, 2021
Sou Extension 1 Filed
Oct 28, 2021
Teas Extension Received
May 11, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 16, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 16, 2021
Published For Opposition
Feb 24, 2021
Notification Of Notice Of Publication E-Mailed
Feb 5, 2021
Approved For Pub - Principal Register
Jan 26, 2021
Teas/Email Correspondence Entered
Jan 26, 2021
Correspondence Received In Law Office
Jan 26, 2021
Teas Request For Reconsideration Received
Jul 29, 2020
Notification Of Final Refusal Emailed
Jul 29, 2020
Final Refusal E-Mailed
Jul 29, 2020
Final Refusal Written
Jun 26, 2020
Teas/Email Correspondence Entered
Jun 25, 2020
Correspondence Received In Law Office
Jun 25, 2020
Teas Response To Office Action Received
Dec 26, 2019
Notification Of Non-Final Action E-Mailed
Dec 26, 2019
Non-Final Action E-Mailed
Dec 26, 2019
Non-Final Action Written
Dec 19, 2019
Assigned To Examiner
Sep 25, 2019
New Application Office Supplied Data Entered In Tram
Sep 23, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24